Ensure access to the patient's electronic health record, current medication containers or lists, and pharmacy refill history. Confirm patient identity and establish a quiet, private environment for the consultation.
No physical recovery is required. Provide the patient with a finalized, reconciled medication list and educate them on any changes made. Advise the patient to report any new side effects immediately and to present the updated list at all future medical appointments.
Comprehensive Guide: The Clinical Imperative of Drug History Review
In the modern clinical landscape, the "Drug History Review" (DHR) is not merely a clerical administrative task; it is a fundamental diagnostic and safety procedure that serves as the bedrock of patient outcomes. As an orthopedic and clinical specialist, I define the DHR as a systematic, high-fidelity assessment of a patient’s current and past medication usage—including prescription drugs, over-the-counter (OTC) supplements, vitamins, and herbal remedies—designed to mitigate iatrogenic risks, optimize surgical readiness, and ensure pharmacotherapeutic synergy.
This guide provides an exhaustive analysis of the DHR process, specifically tailored for surgical and orthopedic preoperative optimization.
1. Technical Specifications and Mechanism of Action
The DHR operates on the principle of Medication Reconciliation (MedRec). It is a multi-step verification process that ensures the patient’s medical chart accurately reflects the reality of their physiological chemical load.
The Mechanism of Clinical Assessment
- Verification: Collecting the most accurate list possible by comparing the patient’s own records with pharmacy databases and prior clinical history.
- Clarification: Ensuring that the dosage, frequency, route, and indication for each medication are consistent with the patient’s clinical status.
- Reconciliation: Identifying discrepancies (e.g., omissions, therapeutic duplications, or contraindicated interactions) and resolving them through evidence-based clinical reasoning.
The Pharmacokinetic Impact
In orthopedic surgery, the DHR is critical because drugs directly influence:
* Coagulation Cascades: Antiplatelets and anticoagulants must be managed to prevent intraoperative hemorrhage.
* Osteoblast/Osteoclast Activity: Long-term bisphosphonate or corticosteroid use can alter bone density and healing potential.
* Anesthetic Potentiation: Interactions between chronic sedative medications and general anesthesia can lead to respiratory depression or delayed recovery.
2. Extensive Clinical Indications & Usage
A Drug History Review is mandatory in, but not limited to, the following clinical scenarios:
| Scenario | Clinical Rationale |
|---|---|
| Preoperative Orthopedic Surgery | Assessing risk of DVT, bleeding, and bone density changes. |
| Acute Pain Management | Reviewing opioid tolerance levels to prevent under-treatment of pain. |
| Polypharmacy (>5 drugs) | Identifying potential adverse drug-drug interactions (ADIs). |
| Elderly/Geriatric Care | Assessing for Beers Criteria medications that increase fall risk. |
| Renal/Hepatic Impairment | Adjusting dosage to prevent systemic toxicity. |
Patient Pre-op Preparation
Patients must be instructed to bring "Brown Bags"—a physical collection of all medications currently in their home. Digital snapshots of labels are acceptable, but physical verification is the gold standard to ensure compliance with dosage instructions.
3. The Procedure: A Step-by-Step Clinical Protocol
A high-quality DHR follows a rigid, reproducible workflow.
Phase I: Data Acquisition
- The Interview: Utilize open-ended questions. Avoid "Are you taking your meds?" and instead ask, "Tell me about the medications you take when you feel pain, and what supplements do you take for your joint health?"
- Collateral Verification: Accessing State Prescription Drug Monitoring Programs (PDMPs) to verify controlled substance history.
Phase II: Analysis and Reconciliation
- Review for Contraindications: Cross-referencing medications against the planned orthopedic procedure (e.g., stopping NSAIDs 7–10 days before surgery due to platelet inhibition).
- Identifying Therapeutic Duplication: Ensuring the patient is not taking multiple medications within the same class (e.g., two different NSAIDs), which exponentially increases the risk of gastric ulcers and renal failure.
Phase III: The Action Plan
- The "Stop/Continue" List: Providing the patient with a clear, written, color-coded schedule of when to cease specific medications before surgery and when to resume them.
4. Risks, Side Effects, and Contraindications
Failure to perform an exhaustive DHR leads to catastrophic outcomes.
Potential Complications of Inadequate DHR
- Hemorrhagic Events: Resulting from the failure to cease anticoagulants (Warfarin, Clopidogrel, DOACs).
- Adrenal Crisis: Occurring in patients on chronic corticosteroids who are not properly "bridged" or supplemented during the stress of surgery.
- Delirium: Often caused by anticholinergic burden in elderly patients, which can be exacerbated by post-operative anesthetic agents.
- Drug-Induced Osteoporosis: Failure to identify long-term proton pump inhibitor (PPI) use, which interferes with calcium absorption and bone remodeling.
5. Post-Op Recovery Protocol
The DHR does not end with the incision. Post-operative recovery requires a "Re-Reconciliation."
- The 24-Hour Check: Assessing if the patient has resumed their home medications safely.
- The "Taper" Review: For patients placed on post-operative opioids, a DHR is required to ensure they are de-escalating usage according to the pain management protocol, preventing long-term dependence.
- Nutritional/Supplement Review: Identifying if home-based supplements (e.g., high-dose Vitamin E or Garlic extract) should remain discontinued to prevent post-surgical complications.
6. Alternative Treatments and Management Strategies
While there is no "alternative" to a drug history review, there are alternative methods of management:
* Pharmacogenomic Testing: For patients with complex medication histories, genetic testing can predict how a patient will metabolize specific drugs, allowing for personalized dosing.
* Pharmacist-Led Medication Therapy Management (MTM): Outsourcing the deep-dive reconciliation to a clinical pharmacist, which statistically improves outcomes in high-risk orthopedic cohorts.
7. Frequently Asked Questions (FAQ)
Q1: Why are herbal supplements included in the DHR?
A: Many herbal supplements (e.g., St. John’s Wort, Gingko Biloba) have significant anticoagulant properties or alter liver enzyme metabolism, which can interfere with anesthesia and increase bleeding risks.
Q2: What is the most dangerous class of drugs in orthopedic surgery?
A: Anticoagulants and antiplatelets are the most critical to manage, as they directly impact the ability to perform surgery safely.
Q3: How often should a DHR be performed?
A: At every transition of care: hospital admission, transfer between units, and discharge.
Q4: Can a patient's family member provide the drug history?
A: Yes, if the patient is cognitively impaired, but the history must be verified against pharmacy records to ensure accuracy.
Q5: What should I do if a patient admits to "non-compliance"?
A: Document the non-compliance clearly. Do not judge; understand the barrier (e.g., cost, side effects, or confusion) and provide educational resources.
Q6: Does a DHR prevent all drug errors?
A: No, but it significantly reduces the likelihood of adverse events by identifying errors in the transition of care.
Q7: How does the DHR impact surgical scheduling?
A: If a patient is found to be on a medication that requires a long washout period (e.g., specific biologics), the surgery may need to be delayed to ensure patient safety.
Q8: Are over-the-counter vitamins included in the DHR?
A: Absolutely. High doses of certain vitamins (like Vitamin A or E) can influence skin healing and bleeding.
Q9: What is the "Beers Criteria" in the context of a DHR?
A: It is a list of medications that are potentially inappropriate for use in older adults because the risks of side effects outweigh the benefits.
Q10: Who is ultimately responsible for the DHR?
A: While nurses and pharmacists often initiate the process, the attending surgeon or primary physician is legally and clinically responsible for the final reconciliation and the decision to proceed with care based on those findings.
8. Conclusion
The Drug History Review is the clinical equivalent of a pre-flight checklist for an aviator. In the orthopedic theater, where the margins for error are narrow and the physiological demands of surgery are high, the DHR is the single most effective tool for preventing avoidable harm. By treating the DHR as a rigorous, data-driven procedure rather than a formality, clinicians can significantly improve patient safety, reduce post-operative complications, and ensure that the chosen orthopedic intervention is supported by a stable, well-managed pharmacological profile.
Clinical Recommendation: Every clinical facility should implement an electronic, automated DHR system that integrates with local pharmacy databases to ensure that the "human element" of data collection is bolstered by the precision of digital health informatics.